DBV Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DBVT and buy or sell other stocks, ETFs, and their options commission-free!About DBVT
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients.
CEODaniel Tassé
CEODaniel Tassé
Employees125
Employees125
HeadquartersChatillon, Hauts-de-France
HeadquartersChatillon, Hauts-de-France
Founded2002
Founded2002
Employees125
Employees125
DBVT Key Statistics
Market cap879.04M
Market cap879.04M
Price-Earnings ratio-4.05
Price-Earnings ratio-4.05
Dividend yield—
Dividend yield—
Average volume351.19K
Average volume351.19K
High today$14.58
High today$14.58
Low today$13.84
Low today$13.84
Open price$13.87
Open price$13.87
Volume402.59K
Volume402.59K
52 Week high$26.19
52 Week high$26.19
52 Week low$8.70
52 Week low$8.70
DBVT News
TipRanks 6d
DBV Technologies announces sale of $50M of ADSs through ATM programDBV Technologies (DBVT) announced that, pursuant to the company’s At-The-Market Program established on September 1, 2025 and included in a new registration stat...
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
0%
Sell
11.1%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.